Effect of remimazolam besylate vs propofol on incidence of postoperative delirium in older patients undergoing hip surgery: a randomized noninferiority trial
- PMID: 38990287
- PMCID: PMC11745690
- DOI: 10.1097/JS9.0000000000001908
Effect of remimazolam besylate vs propofol on incidence of postoperative delirium in older patients undergoing hip surgery: a randomized noninferiority trial
Conflict of interest statement
None of the authors report having a conflict of interest of this study.
Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
Figures
References
-
- Schuttler J, Eisenried A, Lerch M, et al. . Pharmacokinetics and pharmacodynamics of remimazolam (CNS 7056) after continuous infusion in healthy male volunteers: part I. pharmacokinetics and clinical pharmacodynamics. Anaesthesiology 2020;132:636–651. - PubMed
-
- Sneyd JR, Rigby-Jones AE. Remimazolam for anaesthesia or sedation. Curr Opin Anaesthesiol 2020;33:506–511. - PubMed
-
- Keam SJ. Remimazolam: first approval. Drugs 2020;80:625–633. - PubMed
LinkOut - more resources
Full Text Sources
